SG11201807487WA - Generation of midbrain-specific organoids from human pluripotent stem cells - Google Patents

Generation of midbrain-specific organoids from human pluripotent stem cells

Info

Publication number
SG11201807487WA
SG11201807487WA SG11201807487WA SG11201807487WA SG11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA
Authority
SG
Singapore
Prior art keywords
midbrain
singapore
international
deriving
tissues
Prior art date
Application number
SG11201807487WA
Inventor
Junghyun Jo
Huck Hui Ng
Hyunsoo Shawn Je
Original Assignee
Agency Science Tech & Res
Nat Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res, Nat Univ Singapore filed Critical Agency Science Tech & Res
Publication of SG11201807487WA publication Critical patent/SG11201807487WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/72—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/78—Cellulose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization 111111110111101110101011111010111110111011110011010111111111111101111011111 International Bureau 0.. .1 j ..... ..or::,„, (10) International Publication Number (43) International Publication Date WO 2017/160234 Al 21 September 2017 (21.09.2017) WIP0 I PCT _ (51) (21) (22) (25) Filing Language: (26) Publication Language: (30) (71) (72) Inventors: JO, Junghyun; c/o Genome Institute of Singa- International Patent Classification: (74) Agent: SPRUSON & FERGUSON (ASIA) PTE LTD; C12N 5/0793 (2010.01) P.O. Box 1531, Robinson Road Post Office, Singapore International Application Number: 903031 (SG). PCT/SG2017/050126 (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, International Filing Date: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, 14 March 2017 (14.03.2017) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, English KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, Priority Data: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, 10201601965P 14 March 2016 (14.03.2016) SG NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, Applicants: AGENCY FOR SCIENCE, TECHNO- TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, LOGY AND RESEARCH [SG/SG]; 1 Fusionopolis Way, ZA, ZM, ZW. #20-10 Connexis North Tower, Singapore 138632 (SG). NATIONAL UNIVERSITY OF SINGAPORE [SG/SG]; (84) Designated States (unless otherwise indicated, for every 21 Lower Kent Ridge Road, Singapore 119077 (SG). kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, pore, 60 Biopolis Street, #02-01, Genome, Singapore TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, 138672 (SG). NG, Huck Hui; c/o Genome Institute of DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Singapore, 60 Biopolis Street, #02-01, Genome, Singapore LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, 138672 (SG). JE, Hyunsoo Shawn; c/o Duke-NUS Med- SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, ical School, 8 College Road, Level 5, #05-17, Singapore GW, KM, ML, MR, NE, SN, TD, TG). 169857 (SG). Declarations under Rule 4.17: — of inventorship (Rule 4.1 7(iv)) [Continued on next page] — _ = — — = (54) Title: GENERATION OF MIDBRAIN-SPECIFIC ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS FIG. I A = = = = r Poor piau , mf9urt•on a Organo.d ce,-.1opment = ' , a:L. il V dr...I. '':b. , .1v :.,:.,. Velt\" : , l,t Ir.:1..c: ',Awl - 9 i,•: , ,k. ,- . • .,, - = = unitormel t: ., :1 0 000 c.d1 , . = = = _ : The present disclosure provides a (a) culturing pluripotent stem cells to obtain neuronal from (a) to obtain midbrain regionalized tissues; (c) embedding and culturing matrix to obtain neuroepithelial tissues; and (c) culturing the neuroepithelial Also disclosed herein are culture media suitable for deriving and maintaining neuronal TGF-13 Inhibitor and/or SMAD2/3 inhibitors; and midbrain regionalized tissues comprising (a) signaling protein; and (d) fibroblast growth comprising (a) hedgehog signaling protein; and (b) fibroblast growth a midbrain-like organoid comprising (a) neurotrophin tracellular ing N hedgehog taming ', e.c7ociern , method of deriving and maintaining lineage embryoid (b) WNT-signaling activator; culture media suitable for deriving and maintain - TGF-13 Inhibitor and/or factor; culture media factor; (b) ascorbic ri r ,, a bodies; (b) culturing the neuronal lineage embryoid bod- the midbrain SMAD2/3 inhibitors; suitable for deriving factor and culture media suitable for deriving and main - acid; tissues from (c) to obtain a midbrain-like or - \"I c, midbrain-like organoid in culture, compris - regionalized tissues from (b) in an ex - lineage embryoid bodies comprising (b) WNT-signaling activator; (c) and maintaining neuroepithelial tis - and (c) activator of cAMP-dependent path - 11 7r en (57) N ing e ies I-1 ---.. ganoid. ' L ---- (a) 0 sues .,- way. WO 2017/160234 Al 1#1101MOHIMIRME DEM1100110111100IMMEHOIS • \"\"\"°\"\"`' — with sequence listing part of description (Rule 5.2(a)) — with international search report (Art. 21(3))
SG11201807487WA 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells SG11201807487WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201601965P 2016-03-14
PCT/SG2017/050126 WO2017160234A1 (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Publications (1)

Publication Number Publication Date
SG11201807487WA true SG11201807487WA (en) 2018-09-27

Family

ID=59851957

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201807487WA SG11201807487WA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells
SG10201913687VA SG10201913687VA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201913687VA SG10201913687VA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Country Status (5)

Country Link
US (1) US20190169576A1 (en)
EP (1) EP3430132A4 (en)
CN (1) CN109996870B (en)
SG (2) SG11201807487WA (en)
WO (1) WO2017160234A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
CN113249297A (en) 2014-05-28 2021-08-13 儿童医院医疗中心 Methods and systems for converting precursor cells to stomach tissue via directed differentiation
US11584916B2 (en) 2014-10-17 2023-02-21 Children's Hospital Medical Center Method of making in vivo human small intestine organoids from pluripotent stem cells
EP3452578B1 (en) 2016-05-05 2022-08-10 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
US10583286B2 (en) * 2016-08-23 2020-03-10 Boston Scientific Neuromodulation Corporation Methods and devices for neuromodulation of the adrenal gland
NZ753873A (en) 2016-12-05 2023-01-27 Children’S Hospital Medical Center Colonic organoids and methods of making and using same
CN108456659B (en) * 2018-03-14 2020-05-05 浙江霍德生物工程有限公司 Preparation method of 3D brain organoid
CN110295145B (en) * 2018-03-22 2020-10-16 苏州麦迪耐斯医药科技有限公司 Culture solution and culture method for in vitro culture of brain tumor cells
US20220049219A1 (en) * 2018-09-11 2022-02-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Automated generation and analysis of organoids
WO2020100481A1 (en) * 2018-11-15 2020-05-22 Jsr株式会社 Method for producing brain organoids
EP3924468A1 (en) * 2019-02-11 2021-12-22 Miltenyi Biotec B.V. & Co. KG Generation of human pluripotent stem cell derived artificial tissue structures without three dimensional matrices
JP7366332B2 (en) * 2019-06-05 2023-10-23 公立大学法人奈良県立医科大学 Method for producing brainstem organoids
EP4001401A4 (en) * 2019-07-05 2023-07-19 Keio University Production method for cerebral organoid
KR102228400B1 (en) * 2019-09-24 2021-03-16 고려대학교 산학협력단 Method for preparing brain organoid
JP2023503302A (en) * 2019-11-22 2023-01-27 ノヴォ ノルディスク アー／エス Spin-aggregated neural microspheres and their applications
WO2021146349A1 (en) * 2020-01-13 2021-07-22 Aspen Neuroscience, Inc. Method of differentiating neural cells and related compositions and methods of use
US20230165909A1 (en) * 2020-04-21 2023-06-01 Aspen Neuroscience, Inc. Gene editing of lrrk2 in stem cells and method of use of cells differentiated therefrom
WO2021216622A1 (en) * 2020-04-21 2021-10-28 Aspen Neuroscience, Inc. Gene editing of gba1 in stem cells and method of use of cells differentiated therefrom
WO2021232234A1 (en) * 2020-05-19 2021-11-25 武汉睿健医药科技有限公司 Serum-free induction method for sensory neuron cell
US20230323292A1 (en) * 2020-06-08 2023-10-12 Technische Universiteit Eindhoven Methods for producing a (three dimensional) neural tissue
CN115885037A (en) * 2020-06-29 2023-03-31 广东省奥干诺伊德生物科技有限公司 Midbrain organoid, high-speed large-scale production method thereof, method for screening neurotoxic substance and method for screening dopaminergic neuron-related disease drug using the same
KR102346243B1 (en) * 2020-06-29 2022-01-04 주식회사 오간팩토리 Midbrain organoids, high-speed and large-scale manufacturing method thereof, neurotoxic screening methods, and drug screening methods for dopaminergic neuron-related diseases
EP3992280A1 (en) * 2020-10-30 2022-05-04 Kugelmeiers Ltd. Method for the generation of neurospheres
CN114736864B (en) * 2020-12-23 2024-01-26 武汉睿健医药科技有限公司 Neural stem cell induced differentiation culture medium and induced differentiation method
CN113046309B (en) * 2021-03-26 2023-05-05 成都云测医学生物技术有限公司 Culture medium for suspension culture of brain organoids and application thereof
CN113249319B (en) * 2021-05-19 2022-11-11 北京大学 Culture medium and culture method for cerebrospinal fluid organoid
CN113789301B (en) * 2021-08-27 2022-05-10 广州瑞臻再生医学科技有限公司 Method for preparing high-purity induced pluripotent stem cell-derived human brain dopaminergic neuron
CN113493768B (en) * 2021-09-06 2021-12-24 中国科学院动物研究所 Neural organoids and methods of making the same
KR20230081737A (en) * 2021-11-29 2023-06-08 주식회사 오간팩토리 Liver organoids, high-speed and large-scale manufacturing method thereof, and drug efficacy and toxicity screening methods using the same
WO2023137200A2 (en) * 2022-01-13 2023-07-20 The Board Of Trustees Of The Leland Stanford Junior University Generation of neural organizer organoids and midline assembloids from human pluripotent stem cells
CN115404218B (en) * 2022-01-13 2024-09-24 南华大学附属第一医院 3D human brain organoid culture method containing glial cells
CN115851575A (en) * 2022-01-17 2023-03-28 滨州医学院 Culture medium for culturing stomach organoid and application thereof
WO2023201046A1 (en) * 2022-04-14 2023-10-19 Lieber Institute, Inc. Compositions and method for the treatment of x-linked dystonia parkinsonism
EP4286513A1 (en) 2022-06-03 2023-12-06 IMBA-Institut für Molekulare Biotechnologie GmbH Triple tissue culture fusion
WO2024017538A1 (en) * 2022-07-19 2024-01-25 Medizinische Hochschule Hannover Process for producing organoids from mammalian cells
EP4310177A1 (en) * 2022-07-19 2024-01-24 Medizinische Hochschule Hannover Process for producing organoids from mammalian cells
CN115044539A (en) * 2022-08-16 2022-09-13 中义(北京)健康研究院 Shark liver cell and culture method thereof
WO2024113351A1 (en) * 2022-12-02 2024-06-06 Nuwacell Biotechnologies Co., Ltd. Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
CN117778313B (en) * 2024-02-23 2024-05-24 成都云测医学生物技术有限公司 Differentiation method and application of mesenchymal stem cells obtained from brain organoids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
AU2013251749B2 (en) * 2012-04-24 2019-01-17 International Stem Cell Corporation Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells
EP2743345A1 (en) * 2012-12-13 2014-06-18 IMBA-Institut für Molekulare Biotechnologie GmbH Three dimensional heterogeneously differentiated tissue culture
KR101696874B1 (en) * 2013-07-31 2017-01-16 한국생명공학연구원 A method for preparation of induced dopaminergic progenitors using direct reprogramming
DE102014003465A1 (en) * 2014-03-11 2015-09-17 NeuroProof GmbH Obtaining brain region-specific neuronal cultures from three-dimensional tissue cultures of stem cells
JP6718431B2 (en) * 2014-03-21 2020-07-08 フジフィルム セルラー ダイナミクス，インコーポレイテッド Production of midbrain dopaminergic neurons and methods for their use
EP3265104A4 (en) * 2015-03-03 2018-11-07 President and Fellows of Harvard College Methods of generating functional human tissue
LU92845B1 (en) * 2015-10-08 2017-05-02 Univ Du Luxembourg Campus Belval Means and methods for generating midbrain organoids
EP3190176A1 (en) * 2016-01-11 2017-07-12 IMBA-Institut für Molekulare Biotechnologie GmbH Method for tissue culture development on scaffold and differentiated tissue culture

Also Published As

Publication number Publication date
EP3430132A1 (en) 2019-01-23
WO2017160234A1 (en) 2017-09-21
US20190169576A1 (en) 2019-06-06
SG10201913687VA (en) 2020-03-30
CN109996870A (en) 2019-07-09
EP3430132A4 (en) 2019-12-25
CN109996870B (en) 2024-08-13

Similar Documents

Publication Publication Date Title
SG11201807487WA (en) Generation of midbrain-specific organoids from human pluripotent stem cells
SG11201901747VA (en) Inhibitors of cellular metabolic processes
SG11201407486PA (en) Compositions and methods for modulating utrn expression
SG11201901628XA (en) Methods and compositions for spinal cord cells
SG11201806988UA (en) Improved differentiation method
SG11201903155XA (en) Pharmaceutical compounds
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201804363UA (en) Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
SG11201805835WA (en) Modified oncolytic virus
SG11201809064QA (en) Chimeric neurotoxins
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201807720TA (en) Methods and systems for determining antibiotic susceptibility
SG11201804710TA (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
SG11201903032SA (en) Methods and compositions related to nk cell and anti-pdl1 cancer therapies
SG11201406903SA (en) Cell culture compositions and methods for polypeptide production
SG11201407483YA (en) Compositions and methods for modulating smn gene family expression
SG11201900058YA (en) Method of generating mesenchymal stem cells and uses thereof
SG11201909501TA (en) Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro
SG11201906959RA (en) Aryl hydrocarbon receptor (ahr) modulator compounds
SG11201810471YA (en) T cell expansion
SG11201908472VA (en) Compositions and methods for activating nk cells
SG11201909602TA (en) Compositions and methods involving probiotic molecules
SG11201408808WA (en) Method and system for treatment of biological tissue
SG11201900361RA (en) Methods of treating prostate cancer
SG11201809474TA (en) Compositions and methods for bioengineered tissues